On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy. Read more
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.